Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure

NCT00389753 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped study never started

Conditions

Hydration of Scars

Interventions

DRUG: Application of Aruba Aloë formula F-BC-096 or control

Sponsor

University Hospital, Ghent